1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Macrophages protect against sensory axon loss in peripheral neuropathy

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Peripheral neuropathy is a common complication of type 2 diabetes, which is strongly associated with obesity 1 , causing sensory loss and, in some patients, neuropathic pain 2, 3 . Although the onset and progression of diabetic peripheral neuropathy is linked with dyslipidaemia and hyperglycaemia 4 , the contribution of inflammation to peripheral neuropathy pathogenesis has not been investigated. Here we used a high-fat, high-fructose diet (HFHFD), which induces obesity and prediabetic metabolic changes, to study the onset of peripheral neuropathy. Mice fed the HFHFD developed persistent heat hypoalgesia after 3 months, but a reduction in epidermal skin nerve fibre density manifested only at 6 months. Using single-cell sequencing, we found that CCR2 + macrophages infiltrate the sciatic nerves of HFHFD-fed mice well before axonal degeneration is detectable. These infiltrating macrophages share gene expression similarities with nerve-crush-induced macrophages 5 and express neurodegeneration-associated microglial marker genes 6 , although there is no axon loss or demyelination. Inhibiting the macrophage recruitment by genetically or pharmacologically blocking CCR2 signalling resulted in more severe heat hypoalgesia and accelerated skin denervation, as did deletion of Lgals3, a gene expressed in recruited macrophages. Recruitment of macrophages into the peripheral nerves of obese prediabetic mice is, therefore, neuroprotective, delaying terminal sensory axon degeneration by means of galectin 3. Potentiating and sustaining early neuroprotective immune responses in patients could slow or prevent peripheral neuropathy.

          Abstract

          A study in a mouse model of obesity and prediabetes demonstrates that recruitment of macrophages to nerves has a protective role in diet-induced peripheral neuropathy.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: found
          • Article: not found

          IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

          To provide global, regional, and country-level estimates of diabetes prevalence and health expenditures for 2021 and projections for 2045.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression

            Single-cell RNA-seq (scRNA-seq) data exhibits significant cell-to-cell variation due to technical factors, including the number of molecules detected in each cell, which can confound biological heterogeneity with technical effects. To address this, we present a modeling framework for the normalization and variance stabilization of molecular count data from scRNA-seq experiments. We propose that the Pearson residuals from “regularized negative binomial regression,” where cellular sequencing depth is utilized as a covariate in a generalized linear model, successfully remove the influence of technical characteristics from downstream analyses while preserving biological heterogeneity. Importantly, we show that an unconstrained negative binomial model may overfit scRNA-seq data, and overcome this by pooling information across genes with similar abundances to obtain stable parameter estimates. Our procedure omits the need for heuristic steps including pseudocount addition or log-transformation and improves common downstream analytical tasks such as variable gene selection, dimensional reduction, and differential expression. Our approach can be applied to any UMI-based scRNA-seq dataset and is freely available as part of the R package sctransform, with a direct interface to our single-cell toolkit Seurat.
              • Record: found
              • Abstract: found
              • Article: not found

              Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration

              A major challenge in the field of neurodegenerative diseases and brain aging is to identify the body's intrinsic mechanism that could sense the central nervous system (CNS) damage early and protect the brain from neurodegeneration. Accumulating evidence suggests that disease-associated microglia (DAM), a recently identified subset of CNS resident macrophages found at sites of neurodegeneration, might play such a protective role. Here, we propose that microglia are endowed with a dedicated sensory mechanism, which includes the Trem2 signaling pathway, to detect damage within the CNS in the form of neurodegeneration-associated molecular patterns (NAMPs). Combining data from transcriptional analysis of DAM at single-cell level and from human genome-wide association studies (GWASs), we discuss potential function of different DAM pathways in the diseased brain and outline how manipulating DAM may create new therapeutic opportunities.

                Author and article information

                Contributors
                Clifford.Woolf@childrens.harvard.edu
                Journal
                Nature
                Nature
                Nature
                Nature Publishing Group UK (London )
                0028-0836
                1476-4687
                12 February 2025
                12 February 2025
                2025
                : 640
                : 8057
                : 212-220
                Affiliations
                [1 ]Department of Neurobiology, Harvard Medical School, ( https://ror.org/03vek6s52) Boston, MA USA
                [2 ]F.M. Kirby Neurobiology Center, Boston Children’s Hospital, ( https://ror.org/00dvg7y05) Boston, MA USA
                [3 ]Department of Endocrinology, Boston Children’s Hospital, ( https://ror.org/00dvg7y05) Boston, MA USA
                [4 ]Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, ( https://ror.org/046rm7j60) Los Angeles, CA USA
                [5 ]Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, ( https://ror.org/046rm7j60) Los Angeles, CA USA
                Author information
                http://orcid.org/0000-0002-0091-1221
                http://orcid.org/0000-0001-9602-4987
                http://orcid.org/0000-0002-5593-0198
                http://orcid.org/0000-0002-5487-0146
                http://orcid.org/0009-0006-9530-4526
                http://orcid.org/0000-0002-6636-3897
                Article
                8535
                10.1038/s41586-024-08535-1
                11964918
                39939762
                2c33ae85-d5ac-4df5-8fb6-3aa0160e17b6
                © The Author(s) 2025

                Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

                History
                : 2 February 2024
                : 17 December 2024
                Categories
                Article
                Custom metadata
                © Springer Nature Limited 2025

                Uncategorized
                peripheral neuropathies,neuroimmunology
                Uncategorized
                peripheral neuropathies, neuroimmunology

                Comments

                Comment on this article

                Related Documents Log